The metoclopramid-provocation test for prediction of transient hyperprolactinemia during cycle stimulation.
The predictive value of the metoclopramid-provocation test to detect transient hyperprolactinemia during cycle stimulation was assessed. Patients developing hyperprolactinemia during cycle stimulation showed a significantly higher PRL response to the metoclopramid-provocation test before cycle stimulation. The current study confirms previous reports that hyperprolactinemia during cycle stimulation can interfere with follicular and oocyte maturation. The use of the metoclopramid-test can detect an enhanced responsiveness to PRL stimulators and offers the possibility of treatment during cycle stimulation.
Reinthaller
A
A
Second Department of Obstetrics and Gynecology, University of Vienna Medical School, Austria.
Neunteufel
W
W
Bieglmayer
C
C
Fischl
F
F
D004624:Embryo Transfer; D004958:Estradiol / Q000097:blood*; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D006966:Hyperprolactinemia / Q000209:etiology; D008597:Menstrual Cycle; D008787:Metoclopramide; D009865:Oocytes / Q000166:cytology; D011247:Pregnancy; D011374:Progesterone / Q000097:blood*; D011388:Prolactin / Q000097:blood*
D011374:Progesterone; D004958:Estradiol; D011388:Prolactin; D008787:Metoclopramide